Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Vitamin D3 receptor | ||
Ligand | BDBM50198707 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_435196 (CHEMBL904580) | ||
EC50 | 1.1±n/a nM | ||
Citation | Kobayashi, E; Shimazaki, M; Miyamoto, Y; Masuno, H; Yamamoto, K; DeLuca, HF; Yamada, S; Shimizu, M Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position. Bioorg Med Chem15:1475-82 (2007) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Vitamin D3 receptor | |||
Name: | Vitamin D3 receptor | ||
Synonyms: | 1,25-dihydroxyvitamin D3 receptor | NR1I1 | Nuclear receptor subfamily 1 group I member 1 | Retinoic acid receptor RXR-alpha/Vitamin D3 receptor | VDR | VDR_HUMAN | ||
Type: | Protein | ||
Mol. Mass.: | 48288.72 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P11473 | ||
Residue: | 427 | ||
Sequence: |
| ||
BDBM50198707 | |||
n/a | |||
Name | BDBM50198707 | ||
Synonyms: | (2E)-(20S)-1alpha,25-dihydroxy-2-[2''-(fluoroethylidene)]-19-norvitamin D3 | (2Z)-(20S)-1alpha,25-dihydroxy-2-[2''''-(fluoroethylidene)]-19-norvitamin D3 | CHEMBL226380 | CHEMBL388138 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H45FO3 | ||
Mol. Mass. | 448.6535 | ||
SMILES | C[C@@H](CCCC(C)(C)O)C1CCC2\C(CCCC12C)=C\C=C1C[C@@H](O)C(=CCF)[C@H](O)C1 |w:12.11,17.19,9.9,wU:23.25,1.0,wD:29.31,(25.28,-25.48,;26.31,-26.62,;27.81,-26.31,;28.29,-24.84,;29.8,-24.53,;30.28,-23.07,;31.76,-23.5,;28.8,-22.64,;30.67,-21.57,;25.82,-28.08,;26.72,-29.33,;25.81,-30.57,;24.35,-30.1,;23.01,-30.86,;21.68,-30.09,;21.69,-28.55,;23.02,-27.77,;24.35,-28.56,;24.34,-27.01,;23.01,-32.4,;21.69,-33.17,;21.69,-34.71,;23.01,-35.49,;23.01,-37.03,;24.34,-37.8,;21.69,-37.79,;21.69,-39.33,;23.01,-40.1,;24.35,-39.33,;20.36,-37.03,;19.02,-37.8,;20.36,-35.49,)| | ||
Structure |